Install
BIOENGINEER.ORG - Bioengineering
- 26,507articles · 365d
- 19+ min agolatest article
- Sep 13, 2025earliest in window
- 97%with images
- 308avg words
articles per day
Covers
- health 16,719
- research 11,433
- science 10,573
- medical news 10,291
- technology 7,663
- cancer 6,264
- medicine 4,799
- newswise 3,845
- healthcare 3,551
- artificial intelligence 3,549
- lifestyle 3,530
- general 3,088
- ai 2,668
- cell 2,539
- business 2,350
- engineering 2,256
- oncology 2,161
- environment 2,091
- neuroscience 2,076
- all journal news 1,987
People
Places
Organizations
- national institutes of health 5,833
- nature communications 5,322
- world health organization 3,171
- google 3,059
- university of california 2,631
- centers for disease control and prevention 2,032
- national cancer institute 1,897
- mayo clinic 1,756
- us food and drug administration 1,730
- american cancer society 1,499
Categories
- Health & Wellness 15,908
- Science & Technology 13,154
- Science & Nature 12,869
- Medical 12,803
- Health 10,370
- STEM 5,357
- Environment 1,865
- Computers & Electronics 1,236
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
Hold with a pointer, or hold Space or Enter.
News
Could Roche’s Top-Selling Drug Be Harming Women with Primary Progressive
4+ mon, 3+ week ago (1334+ words) The US Food and Drug Administration (FDA) is currently reassessing the approval of Roche’s flagship drug, ocrelizumab (marketed as Ocrevus), specifically for its use in treating primary progressive multiple sclerosis (PPMS). PPMS, a debilitating subtype of multiple sclerosis affecting roughly…...